Amsterdam Public Health
-
Empagliflozin prevents heart failure through inhibition of the NHE1-NO pathway, independent of SGLT2
Chen, S., Wang, Q., Bakker, D., Hu, X., Zhang, L., van der Made, I., Tebbens, A. M., Kovácsházi, C., Giricz, Z., Brenner, G. B. B., Ferdinandy, P., Schaart, G., Gemmink, A., Hesselink, M. K. C., Rivaud, M. R., Pieper, M. P., Hollmann, M. W., Weber, N. C., Balligand, J-L., Creemers, E. E., & 2 others, 2024, (E-pub ahead of print) In: Basic Research in Cardiology.Research output: Contribution to journal › Article › Academic › peer-review
- All publications